ERGIC2 anticorps (C-Term)
Aperçu rapide pour ERGIC2 anticorps (C-Term) (ABIN952104)
Antigène
Voir toutes ERGIC2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 334-362, C-Term
-
Specificité
- This antibody recognizes Human ERGIC2 (C-term).
-
Purification
- Affinity Chromatography on Protein A
-
Immunogène
- KLH conjugated synthetic peptide between 334-362 amino acids from the C-terminal region of Human ERGIC2
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ERGIC2 (ERGIC and Golgi 2 (ERGIC2))
-
Autre désignation
- ERGIC2
-
Sujet
- ERGIC2, or PTX1, is a ubiquitously expressed nuclear protein that is downregulated in prostate carcinoma (Kwok et al., 2001 [PubMed 11445006]).Synonyms: CDA14, ERV41, Endoplasmic reticulum-Golgi intermediate compartment protein 2, PTX1
-
Poids moléculaire
- 42549 Da
-
ID gène
- 51290
-
NCBI Accession
- NP_057654
Antigène
-